Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Glucagon and GLP-1 receptor dual agonist survodutide for obesity: A randomised, double-blind, placebo-controlled, dose-finding phase 2 trial
Safety profile of semaglutide in people aged 55 years and over: pooled data from the PIONEER, SUSTAIN and STEP phase 3 clinical programmes
In Peptide-Based Drug Design ACS Professional Reference Book (eds
GLJ supervised and advised the project
GLP-1s aren't sedating drugs
US$ 25.67
US$ 28.63
US$ 27.80
US$ 23.85
US$ 25.77
US$ 25.45
US$ 29.55
